Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$152,540,743
+$117,661,346 QoQ
Shares Held
2,122,749
+619.4% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#35
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $597,918,972 across 29 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
2,122,749 | $152,540,743 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
618,499 | $104,241,821 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,575,098 | $53,364,320 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
470,051 | $52,147,457 | |
| 5 | ALKS |
Alkermes plc.
|
916,709 | $48,035,551 | |
| 6 | VTRS |
Viatris Inc
|
2,683,275 | $42,610,407 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
504,853 | $32,285,348 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
760,252 | $27,521,122 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,540,743 | 2,122,749 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $34,879,397 | 295,063 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,014,755 | 246,501 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,433,390 | 187,489 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $244,892,338 | 1,570,326 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $27,013,796 | 164,068 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $54,112,148 | 332,119 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $66,207,639 | 338,866 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $54,101,668 | 312,077 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $61,035,739 | 360,710 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $75,404,024 | 382,044 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $67,442,129 | 387,643 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $62,184,169 | 361,095 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $58,178,103 | 349,544 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $56,494,438 | 385,496 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $186,345,810 | 1,256,631 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $238,494,280 | 1,387,482 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $261,622,231 | 1,387,254 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $396,143,660 | 1,623,340 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $318,579,468 | 1,640,978 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $261,108,996 | 1,401,100 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $219,736,725 | 1,395,331 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $240,363,263 | 1,452,346 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $229,534,221 | 1,388,004 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $197,654,162 | 1,442,310 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $115,891,696 | 984,720 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||